Aim: This pilot study examined associations between sleep quality and metabolic risk profiles, underlying hormones, inflammatory markers, and behaviors in overweight and obese young adults, aged 18-29 years. Design: Cross-sectional, descriptive, correlational study design. Method: A partial sample (n ¼ 29) was re-recruited from a parent study on screening for risk of early-onset diabetes. BodyMedia's SenseWear ® armband was used to assess sleep quality. Based on the percentage of consolidated sleep days during the past week, participants were classified as poor, fair, or good sleepers. Multiple multivariate general linear models were used to examine group differences in study variables after adjusting for obesity impact. Results: There were no significant differences among groups in age (mean 23.5 + 2.9 years) or body mass index (mean 38.0 + 8.9 kg/m 2 ). Good sleepers (n ¼ 12, 41.4%) showed the longest nocturnal sleep duration (7:53 + 1:00 hr), followed by fair (n ¼ 12, 41.4%, 7:23 + 1:34 hr) and poor sleepers (n ¼ 5, 17.2%, 5:34 + 0:56 hr). Poor sleepers showed the highest plasma resistin (Z 2 ¼ .103) and ghrelin (Z 2 ¼ .205) levels and caloric (Z 2 ¼ .255) and sodium (Z 2 ¼ .156) intakes. No differences in clinical metabolic markers or serum leptin or adiponectin were observed. Conclusions: Overweight/obese young adults had irregular sleep schedules and patterns, indicators of poor sleep quality, that were possibly associated with changes in dietary behaviors and underlying plasma hormones. In addition to traditional clinical cardiometabolic markers, plasma resistin and ghrelin may be good predictors of heightened vulnerability to cardiometabolic diseases in overweight/obese young adults with poor-quality sleep.
Sleep quality has long been considered an important predictor of health; however, the defining characteristics of good-quality sleep have only recently been identified (Ohayon et al., 2017; Reed & Sacco, 2016) . In 2017, the National Sleep Foundation released age-specific guidelines for assessing sleep quality using a total of 12 indicators. Variables related to sleep continuity (sleep latency, frequency of awakenings lasting greater than 5 min, wake after sleep onset, and sleep efficiency), sleep architecture (rapid eye movement, Stages 1-3, arousal), and napping (frequency of naps per 24 hr, nap duration, and days per week with at least one nap) were included (Ohayon et al., 2017) .
Young adults, aged 18-29 years, transitioning between adolescence and adulthood often voluntarily forgo sleep to meet the challenges of changing roles and perceived mature expectations (Nelson, Story, Larson, Neumark-Sztainer, & Lytle, 2008; Unwin, Goodie, Reamy, & Quinlan, 2013) . Their "night owl" habits are closely associated with behaviors influencing sleep: binge drinking (!5 drinks per day); misuse of substances like tobacco, alcohol, and caffeine; excessive electronic media use; and daytime physical inactivity (National Sleep Foundation, 2014; Schoenborn & Adams, 2008) . Not surprisingly, these behaviors influence young adults' sleep quality. Young adults, aged 18-29 years, show the highest prevalence of sleep disturbance (68%), unintended daytime sleep (44%), medication use to stay awake (11%), and the lowest overall sleep quality (37%) of any age-group, according to the 2002 "Sleep in America" poll, the most recent available sleep data in this age-group (National Sleep Foundation, 2002) .
Poor-quality sleep increases the levels of proinflammatory markers (C-reactive protein and tumor necrosis factor-a [TNFa]; Engin, 2017) . Sleep quality also affects levels of adipocytederived hormones (leptin, adiponectin, and resistin), gut-derived hormones (ghrelin, glucagon-like peptide-1 [GLP-1]), and hormones that directly participate in carbohydrate metabolism like insulin (Guarino, Nannipieri, Iervasi, Taddei, & Bruno, 2017; Morselli, Guyon, & Spiegel, 2012) .
When young adults have poor-quality sleep, their tissues exhibit resistance to the effects of insulin and leptin (DeBoer, 2013; Lopez-Jaramillo et al., 2014) . Leptin resistance activates the sympathetic nervous system, leading to increased cortisol release, endothelial dysfunction, altered lipid metabolism, and decreased insulin but not diminished appetite (Engin, 2017; Morselli et al., 2012) . Insulin insensitivity leads to inappropriately regulated glucose metabolism and early B-cell exhaustion, resulting in early-onset type 2 diabetes and left ventricular hypertrophy (Carnethon et al., 2013) .
Overweight and obese young adults with poor-quality sleep, therefore, have a heightened risk of hypertension, diabetes, and cardiovascular diseases due to the independent, additive risk factors of obesity, sleep, and unhealthy dietary habits induced by appetite-related hormonal imbalances and changes in adipokines (Engin, 2017; Morselli et al., 2012) . However, sleep is rarely included in cardiometabolic prevention strategies (Coughlin & Smith, 2014) , and many overweight and obese young adults with poor-quality sleep are unaware of their heightened vulnerability to cardiometabolic diseases. Consequently, there are few sleep studies of community-dwelling overweight and obese young adults and even fewer studies assessing sleep quality using objective measures.
In the present pilot study, we examined the associations between sleep quality, measured using BodyMedia's SenseWear ® armband, and clinical metabolic risk profiles, underlying hormones, physical activity, and dietary behaviors in overweight and obese young adults. Specifically, we compared sleep duration and patterns (i.e., frequency of awakening > 5 min, duration of awakening during sleep, nap frequency, and ranges of nap time), cardiometabolic risk factors (body mass index [BMI] , blood pressure, lipids, fasting glucose and insulin, glycated hemoglobin [HbA1C]), underlying hormones (leptin, adiponectin, resistin, ghrelin, GLP-1), inflammatory markers (C-reactive protein, TNF-a), dietary behaviors, and physical activity in overweight or obese young adults who were poor-, fair-, or good-quality sleepers.
Method Design
We used a cross-sectional, descriptive correlational design for this pilot study.
Participants
Prior to beginning the study, we obtained approval from the university's institutional review board. We re-recruited a subsample (n ¼ 30) from a parent study aimed at screening for early-onset type 2 diabetes risk in young adults, aged 18-29 years (K01NR012779). Those eligible for the parent study were community-dwelling young adults who were overweight or obese (BMI ! 25 kg/m 2 ) and sedentary (leisure-time physical activity < 90 min/week during the past month). After a phone screening, we invited eligible young adults (n ¼ 106) to the Clinical Research Unit of Atlanta Clinical & Translational Science Institute (ACTSI) to complete anthropometric assessments, behavioral surveys, and fasting blood draws. The details of the participant recruitment for the parent study are described in a previous publication (Cha et al., 2014) .
Data Collection
Once participants completed data collection for the parent study, those interested in participating in the present substudy received a SenseWear armband model MF-SW (BodyMedia, Inc., Pittsburgh, PA) and a self-addressed stamped mailer, with instructions to wear the armband for 7 days continuously, except when taking a shower or swimming. The research team called participants on the first day to remind them how to accurately wear the armband and answer any questions. After 7 days, we called the participants again to remind them to return the armband.
Variables and Measures
During the ACTSI visit, a trained nurse from the ACTSI collected anthropometric data and blood samples, and research staff collected survey data.
Anthropometric data and biomarkers. To determine BMI (kg/m 2 ), we used height and weight measurements. Seated blood pressure (BP) was measured using American Heart Association standard guidelines. Waist circumference (WC) was measured with a tape measure to assess visceral fat. Fasting blood samples were collected to measure plasma glucose, insulin, lipids (total cholesterol, high-density lipoprotein [HDL] , low-density lipoprotein [LDL] , triglycerides, and free fatty acids), hormones affecting glucose metabolism (GLP-1, leptin, ghrelin, resistin, and adiponectin), proinflammatory markers (TNF-a, C-reactive protein), and HbA1c. Plasma samples were processed, and results were reported by a certified Biomarker Core Laboratory. We calculated insulin resistance using the homeostasis model of assessment formula: fasting insulin (mU/ml) Â fasting glucose (mg/dl)/405 (Matthews et al., 1985) . We also calculated the ratio of insulin to glucose levels. We provide a brief review of the impacts obesity and poor-quality sleep have on hormones in Table 1 .
Sleep measures. Subjective assessments of participants' sleep duration were made with 3 items (participants' bedtime, time awakened, and average nocturnal sleep duration during the past month) in the sociodemographic questionnaire. Objective sleep quantity and quality were assessed with the SenseWear armband (armband model MF-SW, software V8.0), a triaxial actimetry monitor of sleep and physical activity. Prior research has validated use of the SenseWear armband in both children and adults (O'Driscoll, Turton, Copland, Strauss, & Hamilton, 2013; Soric et al., 2013) . Skin sensors (for temperature, heat flux, and electrical resistance) and time recordings coupled with accelerometer readings allowed researchers to differentiate between participants' sleep and inactivity conditions. Using the SenseWear Professional Software V8.0 guide and guidance from sleep experts experienced with the SenseWear armband (the last author and a consultant), we calculated the durations of sleep fragments. Body position (lying down), energy expenditure (metabolic equivalent task [MET] < 2), step counts (<10 steps/min over 10 or more consecutive minute), and time stamp were used to determine when patients were lying down and sleeping and to calculate the frequency and duration of these conditions. We then calculated the durations and frequency of naps and nocturnal sleep, the frequency of awakening for >5 min, and the duration of time awake during the sleep period.
We classified sleep-quality groups based on sleep patterns and the number of sleep fragments. Since many of the young 
Survey Questionnaires
Sociodemographics. We collected sociodemographic characteristics, including age, ethnicity, years of education, employment status, smoking, alcohol consumption, and binge drinking habits during the past month, using a sociodemographic questionnaire developed by the first author.
Dietary behaviors. We measured dietary behaviors with the Youth/Adolescent Food Frequency Questionnaire (FFQ), a youth version of the Willett FFQ from the Nurses' Health Study (Rockett et al., 1997) , as recommended by Harvard University School of Public Health. Once we obtained preliminary data from the Harvard University School of Public Health that included a nutritional breakdown of the participants' FFQs, we calculated a Dietary Quality Index Revised for young adults score to assess overall dietary quality, caloric intake, caffeine intake, added sugar intake, and serving sizes (Cha et al., 2014; Newby et al., 2003) .
Physical activity. We assessed physical activity with the 7-Item Modifiable Activity Questionnaire, which researchers used in the Diabetes Prevention Program (Kriska, 1997) . Then, we calculated the activity as metabolic equivalents (MET)-hour per week (Kriska, 1997) .
Data Analysis
Only participants who wore the SenseWear armband for a minimum of 15 hr per day (including the 9:00 p.m. to 9:00 a.m. time period) and at least 3 days of 7 were included in our analysis. We excluded one participant due to inadequate duration of time spent wearing the armband. Thus, 29 participants remained for final data analysis. Descriptive summaries are reported for demographic data. Continuous variables are reported as means and standard deviations; categorical variables are reported as frequencies and percentages. Based on the percentage of days during the past 7 days in which participants reported consolidated sleep (i.e., sleep was not fragmented), the participants were assigned to poor (<33.3% consolidated sleep), fair (33.4-66.6% consolidated sleep), or good (!66.7% consolidated sleep) sleep groups. Age, BMI, dietary and physical activity variables, hormones, cardiometabolic risk profiles, and inflammatory makers were compared among groups using Kruskal-Wallis nonparametric test (a one-way analysis of variance on rank). This approach allows the researchers to test whether samples originate from the same distribution and compare the group differences despite different sample sizes. The Levene's test was also performed to evaluate the equality of variance. A multiple general linear model was constructed to adjust for the obesity effect and thus examine the sleep groups and their associations with anthropometric measures and biomarkers after adjusting for BMI. We used BMI instead of waist circumference to assess the impact of obesity on the study variables because we recognized that accurate assessment of waist circumference in severely obese (BMI > 35 kg/m 2 ) persons is very challenging due to varying distribution of body fat. A p value of <.05 was set, and due to the small sample size, the effect size (partial eta square [Z 2 ]: .02 for small, .13 for medium, and .26 for large) was also reported to indicate potentially significant variables for a larger study in the future. All data analyses were performed using IBM SPSS version 23.0.
Results Sociodemographics
The majority of participants in this study were African American (n ¼ 22, 75.9%) and female (n ¼ 21, 72.4%). The mean age and mean BMI were 23.5 + 2.9 years and 38.0 + 8.7 kg/m 2 , respectively. Half of the participants were full-time students (n¼ 15, 51.7%) and 65.5% (n ¼ 19) never smoked. Mean selfreported daily sleep time during the past month was 6.3 + 1.4 hr (range: 4-10 hr). Since all partipants were obese, metabolic abberation was common. The most prevelant metabolic abberation was low HDL (n ¼ 24, 82.8%), followed by elevated systolic blood pressure (n ¼ 10, 34.5%), HbA1C (n ¼ 9, 31.0%), and LDL (n ¼ 8, 27.6%).
Sleep Duration, Quality, and Patterns Table 2 provides the normal or recommended values for sleep, clinical, behavioral, and cardiometabolic variables and compares the values observed by group in the present study. The most common bedtimes were between 12:01 a.m. and 2:00 a.m. (66 of 144 observations; 45.8%), followed by bedtimes after 2:01 a.m. (43 of 144 observations; 29.9%). Good sleepers went to bed at consistent and earlier times throughout the week (34.92% had bedtimes before 12:00 a.m.), as compared to fair (21.54% had bedtimes before 12:00 a.m.) and poor (10.53% had bedtimes before 12:00 a.m.; 10.53%) sleepers.
While good sleepers in the present study did not awaken during the nocturnal sleep period (median awakenings ¼ 0), the fair and poor sleepers experienced awakenings almost every night (median awakenings ¼ 3.5 and 4 per night, respectively). Fair and good sleepers had similar nocturnal sleep durations, while poor sleepers obtained less sleep at night. Poor and fair sleepers frequently used daytime naps to compensate for insufficient nocturnal sleep.
Clinical Profiles and Behaviors
There were no differences in mean age (23.5 + 2.9, p ¼ .755) or BMI (38.0 + 8.9, p ¼ .534) among the three groups. There were also no significant differences among groups with respect to physical activity although the fair sleepers exhibited the lowest MET-hour/week.
Poor sleepers showed the highest caloric (p ¼ .023, Z 2 ¼ .255), carbohydrate (p ¼ .027, Z 2 ¼ .203), and sodium (p ¼ .039, Z 2 ¼ .156) intakes after adjusting for BMI. However, there were no statistical group differences among the three groups related to alcohol, added sugar, or caffeine consumption and no differences with regard to cardiometabolic risk profiles. Note. N ¼ 29. Values are reported as mean + SD unless otherwise indicated. The Kruskal-Wallis test was performed in light of the small and unequal sample sizes.
Adjusted p values are from the general linear models (GLMs), which were adjusted for BMI effect. Partial Z 2 refer to the effect size. If the adjusted p value is significant but the Kruskal-Wallis test is not, it may indicate the need for a larger sample. If the Kruskal-Wallis test is significant but the GLM result is not, it indicates that there was a group difference but that the BMI may be responsible for the difference. BMI ¼ body mass index; DQIR-Y ¼ Dietary Quality Index Revised for young adults; HbA1C ¼ glycated hemoglobin; HDL ¼ high-density lipoprotein cholesterol; HOMA-IR ¼ homeostasis model of assessment-insulin resistance; LDL ¼ low-density lipoprotein cholesterol; M ¼ men; NEFA ¼ nonesterified fatty acids; W ¼ women.
While fasting insulin level was the highest in good sleepers, there was no group difference. Good sleepers also showed the highest ratio of insulin to glucose, indicating the best insulin secretion and a good response to glucose. Serum cholesterol levels (total cholesterol, triglyceride, and LDL) were highest in fair sleepers but not statistically different from those of other groups (see Table 2 ). 
Comparisons of Underlying Markers: Hormones and Inflammatory Markers

Discussion
Curtailed sleep increases metabolic risk, which can lead to the development of cardiometabolic diseases (Bayon, Leger, Gomez-Merino, Vecchierini, & Chennaoui, 2014) . In the present study, we addressed the additional importance of the effects of sleep quality on metabolic aberration (Morselli et al., 2012) , changes in behaviors, underlying hormones, and inflammatory responses (Engin, 2017; Guarino et al., 2017) . Poor-quality sleep in the participating overweight or obese young adults was not significantly associated with traditional clinical cardiometabolic biomarkers (i.e., fasting serum glucose, insulin, lipids, leptin, adiponectin, and blood pressure); however, we observed potentially detrimental differences in behaviors and levels of metabolic hormones and inflammatory markers.
Overweight and obese young adults who were poor sleepers showed the highest plasma levels of resistin and ghrelin as well as the highest consumption of calories, carbohydrates, and sodium. Plasma resistin may be useful in predicting metabolic aberration when used in conjunction with traditional cardiometabolic clinical markers in overweight and obese persons with leptin resistance. Emphasizing appropriate sodium and carbohydrate intake may be a straightforward dietary intervention that could be implemented in this population to improve cardiometabolic health. Future research with a larger sample and over a longer time period is warranted to further investigate the associations among resistin, ghrelin, and dietary behaviors and to examine when, how, and why these small changes are associated with pathophysiologic processes.
Young adults with good-quality sleep will awaken less than one time per night (Ohayon et al., 2017) . Troublingly, the majority of participants in the present study had more frequent awakenings (mean awakenings/night ¼ 2.31 + 2.69), waking 60-120 min after sleep onset and not returning to sleep for up to 3 hr. The long intervening awake time was associated with a late morning awakening and long (2-3 hr) or frequent (!3/day) naps. These sleep behaviors might generate a vicious cycle of irregular bedtimes, daytime sleepiness, and delayed sleep over consecutive nights. Educating young adults about appropriate sleep behaviors and good sleep hygiene practices may help to improve their sleep quality.
Poor sleepers showed the highest BMI (although it was not significantly different from other sleep groups) and experienced the most frequent awakenings during sleep in the current study. This finding is consistent with those of previous studies that demonstrated that overweight and obese young adults are prone to more fragmented sleep and are vulnerable to obstructive sleep apnea (OSA; Bayon et al., 2014; Schwartz et al., 2008) , with the severity of OSA positively correlated with BMI and neck circumference (Schwartz et al., 2008; Seetho & Wilding, 2014 ). More work is needed to establish associations Note. (N ¼ 29) . Values are reported as mean + SD unless otherwise indicated. The Kruskal-Wallis (K-W) test was performed in light of the small and unequal sample sizes. Adjusted p values are from the general linear models (GLMs), which were adjusted for BMI effect. Partial Z 2 refer to the effect size. If the adjusted p value is significant but the Kruskal-Wallis test is not, it may indicate the need for a larger sample. If the Kruskal-Wallis test is significant but the GLM result is not, it indicates that there was a group difference but that the BMI may be responsible for the difference. GLP-1 ¼ glucagon-like peptide 1; TNF-a ¼ tumor necrosis factor-a. *p < .010. **p < .05.
among OSA, sleep quality, and metabolic aberrations in overweight and obese young adults.
The current pilot study is limited in multiple aspects. First, the small sample size and homogeneity of participants (all participants were overweight and obese young adults) make generalizations to normal-weight young adults problematic. Second, while self-report measures have been determined to be valid and reliable, they may be subject to misrepresentation by respondents due to their nature. Third, there was variability in the length of time participants wore the SenseWear armband, despite instructions to wear it 24 hr/day for 7 days, leading to partial or incomplete records of their sleep patterns. Additionally, objective assessment of physical activity (e.g., steps/day) requires measuring sleep and physical activity together over a full 24-hr period of wearing SenseWear armband. Since many participants did not wear the armband for a continuous 24-hr period, the sample size was further reduced, and the evidence regarding physical activity is inconclusive. Finally, it was difficult to distinguish inactivity from a genuine sleep period. Sleep diaries maintained by participants combined with an objective measure like the SenseWear armband might provide more complete pictures of sleep patterns.
